The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised another clinical trial of a vaccine against COVID-19 in Germany. The intensive preliminary scientific advice of the medicines developer CureVac, and the prioritisation of the regulatory activities at the Paul-Ehrlich-Institut for vaccines and biomedicines against COVID-19 have made it possible to complete the authorisation procedure […]
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has authorised the second clinical study with COVID-19 reconvalescent plasma (RECOVER) in Germany. The purpose of such clinical trials is to gain insights into the safety and efficacy of COVID-19 reconvalescent plasma in the treatment of serious COVID-19 infections. Patients to be treated include old and high-risk […]
In Germany, immunostimulatory products on the basis of bacteria preparations derived from the Bacillus Calmette-Guérin (BCG) mycobacterial strain are authorised for the treatment of urinary bladder carcinoma. The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has issued a warning that the BCG products available in pharmacies are not authorised for the treatment or prevention of […]
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised the first clinical trial of a vaccine against COVID-19 in Germany. Spike-Protein SARS-CoV-2 (Source: Viaframe/Corbis/GettyImages) The authorisation of this trial is the result of a careful assessment of the potential risk/benefit profile of the vaccine candidate. Based on extensive scientific advice to the medicine developer, […]
• Mobilization for Covid-19 emergency aid, of all the funds allocated to the 2020 calls for projects of Fondation PSA • This donation will support the mobility of structures supporting the sick and fragile people “The health crisis we are going through has shown the essential role of mobility in meeting the essential needs of […]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Korean
Portuguese
Russian
Spanish